Dotbee.ai

Analysis StatSure Diagnostic Systems, Inc. (SSUR)

5/27/2024

Analysis StatSure Diagnostic Systems, Inc. (SSUR)

Analysis of StatSure Diagnostic Systems, Inc. (SSUR)

StatSure Diagnostic Systems, Inc. (SSUR) has been trading at a consistent price of 0.00020 for the past several days, with no significant changes in indicators such as RSI, MACD, or moving averages (SMA, EMA, WMA). This stability may indicate a period of consolidation or lack of significant market activity for SSUR.

It is important to monitor any potential catalysts or news developments that could impact the stock price in the future. Additionally, technical analysis tools can be used to identify potential breakout or breakdown points in the price movement of SSUR.

Overall, further analysis and monitoring of SSUR's price action and market conditions are recommended to make informed investment decisions.

Main Statystic 🧠

The company's financials show a strong cash flow, with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet indicates a total cash of $67.15 billion, total debt of $104.59 billion, and a current ratio of 1.037. The book value per share is $4.837, total cash per share is $4.379, and the total debt to equity ratio is 140.968.

In terms of profitability, the profit margin is 26.31% and the operating margin is 30.74%. The company has a return on assets of 22.07% and a return on equity of 147.25%. The most recent quarter ended on March 31, 2024, and the fiscal year ends on September 30, 2023.

From the income statement, we see that EBITDA is $131.39 billion, revenue is $381.62 billion, diluted EPS is $6.44, gross profit is $169.15 billion, revenue per share is $24.54, and net income to common is $100.39 billion. The quarterly revenue growth is -4.3% and the quarterly earnings growth year-over-year is -2.2%.

Moving on to stock statistics, the short ratio is 1.66, with 94.31 million shares shorted out of 1.53 billion float shares. The company has 15.33 billion shares outstanding, with 5.22% held by insiders and 57.56% held by institutions. The short percent of shares outstanding is 0.62%.

In terms of valuation metrics, the PEG ratio is 26.21, forward PE is 26.21, and trailing PE is 29.43. The enterprise value is $2.95 trillion, price to book ratio is 39.18, price to sales ratio is 7.62, enterprise to EBITDA ratio is 22.75, and enterprise to revenue ratio is 7.73. The market capitalization is $2.91 trillion.

Looking at stock price summary, the beta is 1.264, with a 50-day moving average of $173.69 and a 200-day moving average of $180.79. The 52-week low is $164.08, the 52-week high is $199.62, and the 52-week change is 8.25%.

Lastly, in dividends and splits, the company has a payout ratio of 14.93% and a forward annual dividend rate of $1. The dividend date is May 16, 2024, and the ex-dividend date is May 10, 2024. The last split date was August 31, 2020, with a 4-for-1 split. The 5-year average dividend yield is 0.73%, the forward annual dividend yield is 0.53%, and the trailing annual dividend yield is 0.51%.

Income statement 💸

These are the revenue figures. Here are the conclusions:

1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating a potential need for cost management.
3. The gross profit margin has remained relatively stable over the years, suggesting efficient cost control measures.
4. Earnings before interest and taxes (EBIT) have shown an upward trend, reaching $117.7 billion in 2023 from $69.9 billion in 2020.
5. Net income has also been increasing consistently, from $57.4 billion in 2020 to $97 billion in 2023.
6. The company has been able to maintain a healthy EBITDA margin over the years, indicating operational efficiency.
7. Diluted earnings per share (EPS) have shown a slight fluctuation but have generally been on an upward trajectory.
8. The company's effective tax rate has remained relatively stable, indicating consistent tax planning strategies.
9. Overall, the financial performance of the company in terms of revenue and profitability has been positive and improving over the years.

Balance Sheet

These are balance sheets. Here are the conclusions:

1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets include cash, inventory, and receivables, with cash and cash equivalents showing fluctuations.
3. Non-current assets consist mainly of investments and advances, with a significant portion allocated to machinery, furniture, and equipment.
4. Total liabilities have also been on the rise, with the highest value recorded at $302,083,000,000 in 2022.
5. Current liabilities involve short-term debt, accounts payable, and other current liabilities.
6. Non-current liabilities include long-term debt and other non-current liabilities.
7. Shareholders' equity has shown variations, with the highest value of $90,488,000,000 in 2019.
8. Common stock and retained earnings are the major components of shareholders' equity.
9. The accumulated depreciation of non-current assets has been increasing, indicating the aging of assets over time.

Earnings

The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous results, ending on February 27, 2025, were handled by the Transfer Agent. The results from January 31, 2025, were released after hours. The results from October 31, 2024, were not provided at this time. The results from August 1, 2024, showed an earnings per share (EPS) estimate of 1.33.

Cash Flow 💶

This is the cash flow statement. Here are some conclusions we can draw from the data:

1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational performance and strategic investments.

Earnings estimate

The analysts' estimates for future quarterly and annual earnings per share are as follows:

1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.33
- Low Estimate: $1.27
- High Estimate: $1.36
- Year Ago EPS: $1.26
- Number of Analysts: 26

2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.53
- Low Estimate: $1.44
- High Estimate: $1.63
- Year Ago EPS: $1.46
- Number of Analysts: 25

3. Current Year (as of September 30, 2024):
- Average Estimate: $6.59
- Low Estimate: $6.43
- High Estimate: $6.92
- Year Ago EPS: $6.13
- Number of Analysts: 39

4. Next Year (as of September 30, 2025):
- Average Estimate: $7.23
- Low Estimate: $6.40
- High Estimate: $7.90
- Year Ago EPS: $6.59
- Number of Analysts: 39

Based on these estimates, we can see a generally positive trend in the expected earnings per share for both the upcoming quarters and the next two years. The average estimates show an increase compared to the year-ago EPS figures, indicating potential growth in earnings for the company.

Revenue estimate

Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:

1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.

2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.

3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.

4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.

These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.

Growth estimates

Based on the consensus estimates provided:
- The current year growth rate is 7.5%
- The next quarter growth rate is 4.8%
- The current quarter growth rate is 5.6%
- The next year growth rate is 9.7%
- The next 5 years compound annual growth rate (CAGR) is 11%
- The past 5 years compound annual growth rate (CAGR) is 20.15%

It can be observed that the company is expected to experience a significant decrease in growth rate compared to the past 5 years, with a notable drop from 20.15% CAGR to 11% CAGR for the next 5 years. Additionally, there is a slight increase in growth expected for the next year compared to the current year.

Price target

The analysts' forecast for the future price of the security is as follows:
- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD

Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security, with the low end at $164, the high end at $250, and the average at $202.26. The current price is below both the average and median forecast, indicating that there is potential upside according to the analysts' predictions.

MACD of SSUR

This is not investment advice. Remember to verify the information provided here.

Get access to the full analysis

  • Over 35 000 indexes
  • CFD, Forex, Crypto and Stocks Exchange
  • Over 150 Indicators
  • Pattern and candle analysis
  • Support and resistance levels
  • Fundamental, technical and sentimental analysis
  • Power from AI
Web versionApp StoreGoogle Play

Contacts

Telephone number

+48 32 700 81 66

Email address

[email protected]

Company information

Honey Payment Group S.A. at Al. Aleje Jerozolimskie 65 / 79, 00-697 Warsaw, Poland, Register number KRS 0000335507, NIP 5252859204, REGON 388760204. Honey Payment Group is listed on the Warsaw Stock Exchange (WSE) under the ticker symbol HPG. Link